Third Quarter 2018 Results

Bayer AG News Conference Call

Bayer: Good performance in a challenging environment, Group outlook confirmed

Group sales increase by 1.9 percent (Fx & portfolio adj.) to 9.905 billion euros / EBITDA before special items level year on year at 2.202 billion euros / Business performance at Pharmaceuticals remains strong / Consumer Health with increase in sales (Fx & portfolio adj.), while currency effects weigh on earnings / Crop Science posts substantial rise in sales and earnings due to acquisition – successful start to integration process / Sales and earnings of Animal Health decline following a strong second quarter / One-time gain (before taxes) of roughly 3.9 billion euros from divestments / Net income 2.886 billion euros / Core earnings per share 1.19 euros / Adjusted 2018 Group outlook confirmed
more

Links

Speaker

Werner Baumann, CEO of Bayer AG

Werner Baumann
CEO of Bayer AG

Wolfgang Nickl, CFO of Bayer AG

Wolfgang Nickl
CFO of Bayer AG

Follow us:

Twitter

Twitter
You will find the key statements on » Twitter